Cheng‐Hsun Lu

967 total citations
41 papers, 651 citations indexed

About

Cheng‐Hsun Lu is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, Cheng‐Hsun Lu has authored 41 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Cheng‐Hsun Lu's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Cheng‐Hsun Lu is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Cheng‐Hsun Lu collaborates with scholars based in Taiwan, United States and Malaysia. Cheng‐Hsun Lu's co-authors include Song‐Chou Hsieh, Yi‐Cheun Yeh, Ko‐Jen Li, Chieh‐Yu Shen, Chia‐Li Yu, Chih-Hao Wu, Yu‐Min Kuo, Chia‐Hsiang Yang, Chih‐Yu Kuo and Chang‐Youh Tsai and has published in prestigious journals such as International Journal of Molecular Sciences, Small and Annals of the Rheumatic Diseases.

In The Last Decade

Cheng‐Hsun Lu

36 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Hsun Lu Taiwan 14 120 111 105 93 87 41 651
C. LaShan Simpson United States 9 89 0.7× 47 0.4× 137 1.3× 68 0.7× 40 0.5× 15 488
Chien‐Ming Chen Taiwan 18 36 0.3× 41 0.4× 140 1.3× 85 0.9× 42 0.5× 73 882
Yingjin Wang China 17 48 0.4× 195 1.8× 326 3.1× 91 1.0× 24 0.3× 34 965
Chenguang Niu China 22 30 0.3× 147 1.3× 480 4.6× 97 1.0× 34 0.4× 49 1.1k
Yiwen Niu China 10 71 0.6× 61 0.5× 95 0.9× 48 0.5× 11 0.1× 33 580
Peilang Yang China 13 26 0.2× 234 2.1× 415 4.0× 66 0.7× 26 0.3× 26 1.1k
Xiangling Chen China 14 31 0.3× 189 1.7× 351 3.3× 41 0.4× 14 0.2× 24 1.1k
Patricia García‐García Spain 12 21 0.2× 28 0.3× 157 1.5× 151 1.6× 29 0.3× 34 541
Yeon Kim South Korea 16 40 0.3× 68 0.6× 302 2.9× 95 1.0× 18 0.2× 59 806

Countries citing papers authored by Cheng‐Hsun Lu

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Hsun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hsun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hsun Lu more than expected).

Fields of papers citing papers by Cheng‐Hsun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hsun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hsun Lu. The network helps show where Cheng‐Hsun Lu may publish in the future.

Co-authorship network of co-authors of Cheng‐Hsun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Hsun Lu. A scholar is included among the top collaborators of Cheng‐Hsun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Hsun Lu. Cheng‐Hsun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Feng‐Cheng, Cheng‐Hsun Lu, Chang‐Fu Kuo, et al.. (2025). Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real‐World Study in Taiwan. International Journal of Rheumatic Diseases. 28(6). e70285–e70285.
3.
Lu, Cheng‐Hsun, Chieh‐Yu Shen, Ko‐Jen Li, et al.. (2024). Resolution of acute inflammation induced by monosodium urate crystals (MSU) through neutrophil extracellular trap-MSU aggregate-mediated negative signaling. Journal of Inflammation. 21(1). 50–50. 3 indexed citations
4.
Tseng, Tai‐Chung, Shang‐Chin Huang, Chieh‐Yu Shen, et al.. (2024). Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus. Clinical and Experimental Rheumatology. 42(9). 1830–1837.
5.
Hsieh, Tsu‐Yi, Ming‐Han Chen, Cheng‐Hsun Lu, et al.. (2023). Rituximab induction and reinduction in granulomatosis with polyangiitis and microscopic polyangiitis: A retrospective multicenter study in Taiwan. International Journal of Rheumatic Diseases. 26(12). 2441–2449.
6.
Tsai, Chang‐Youh, Ko‐Jen Li, Chieh‐Yu Shen, et al.. (2023). Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis. International Journal of Molecular Sciences. 24(12). 10066–10066. 12 indexed citations
7.
Shen, Chieh‐Yu, Ko‐Jen Li, Chih-Hao Wu, et al.. (2023). Unveiling the molecular basis of inflamm-aging induced by advanced glycation end products (AGEs)-modified human serum albumin (AGE-HSA) in patients with different immune-mediated diseases. Clinical Immunology. 252. 109655–109655. 4 indexed citations
8.
Lai, Tso‐Ting, Cheng‐Hsun Lu, Yi‐Ting Hsieh, et al.. (2022). Characteristics and Potential Risk Factors of Hydroxychloroquine Retinopathy in Patients with Systemic Lupus Erythematosus: Focusing on Asian Population. Journal of Ocular Pharmacology and Therapeutics. 38(10). 728–733. 6 indexed citations
9.
Huang, Yimin, Cheng‐Hsun Lu, Chieh‐Yu Shen, et al.. (2022). Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia. International Journal of Infectious Diseases. 122. 1018–1025. 3 indexed citations
10.
Liao, Hsien‐Tzung, Chang‐Youh Tsai, Chien‐Chih Lai, et al.. (2022). The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis. Frontiers in Cell and Developmental Biology. 9. 748063–748063. 13 indexed citations
12.
Lu, Cheng‐Hsun, et al.. (2021). Pregnancy outcomes in patients treated with belimumab: Report from real-world experience. Seminars in Arthritis and Rheumatism. 51(5). 963–968. 22 indexed citations
13.
Lu, Cheng‐Hsun, et al.. (2021). Engineering nanocomposite hydrogels using dynamic bonds. Acta Biomaterialia. 130. 66–79. 79 indexed citations
14.
Kuo, Yu‐Min, et al.. (2021). Increased heterogeneity of brain perfusion predicts the development of cerebrovascular accidents. Medicine. 100(15). e25557–e25557. 1 indexed citations
15.
Lu, Cheng‐Hsun & Yi‐Cheun Yeh. (2021). Fabrication of Multiresponsive Magnetic Nanocomposite Double‐Network Hydrogels for Controlled Release Applications. Small. 17(52). e2105997–e2105997. 32 indexed citations
16.
Chen, You‐Yi, Ming‐Chieh Shih, Yimin Huang, et al.. (2021). Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome—A Retrospective Cohort Study. Frontiers in Medicine. 8. 755147–755147. 1 indexed citations
18.
Lu, Cheng‐Hsun, et al.. (2019). A 2.25 TOPS/W Fully-Integrated Deep CNN Learning Processor with On-Chip Training. 65–68. 18 indexed citations
19.
Lu, Cheng‐Hsun, et al.. (2014). Rituximab for refractory digital infarcts and ulcers in systemic sclerosis. Clinical Rheumatology. 33(7). 1019–1020. 15 indexed citations
20.
Wei, Shu‐Chen, et al.. (2014). Patients with Inflammatory Bowel Disease have Higher Sonographic Enthesitis Scores than Normal Individuals: Pilot Study in Taiwan. Journal of Medical Ultrasound. 22(4). 194–199. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026